Welcome to our book review site go-pdf.online!
You may have to Search all our reviewed books and magazines, click the sign up button below to create a free account.
Modern Trends in Human Leukemia VI
Organized on behalf of the Deutsche Gesellschaft für Hämatologie und Onkologie. Wilsede, June 17-20, 1984 Wilsede Joint Meeting on Pediatric Oncology III. Hamburg, June 21/22, 1984.
Modern Trends in Human Leukemia VIII
You see things, and sa)' why? But I dream 1hings that never were, and I say, 11'hy 110t? George Bernhard Shaw Far ahead of his time, June 1st, 1909, Alexander Maximov communicated in a lecture, given in the Charite in Berlin, the fundamental knowledge, that there exists a lymphoid hemopoetic stem cell. Alexander Friedenstein explained that during the following years, Maximov also showed that the idea of interaction between hemopoetic cells and their stroma to be one of the most significant experiences. Monoclonal antibodies, recombinant DNA technics and the improvement of tissue culture models are the major developments to improve our possibilities to clarify growth and differentiation funct...
Modern Trends in Human Leukemia IX
This volume provides a comprehensive account of the most recent trends in human leukemia, as presented at the Ninth Wilsede Meeting. The internationally renowned contributors deal with all different aspects of these diseases: As well as discussing important clinical aspects of leukemia, new information on the biological basis of leukemia gained using the methods of molecular genetics, cell and molecular biology, virology, and immunology is covered. The book shows both the complexity of leukemia research, as well as the value of basic scientific research in furthering clinical medicine and therapy.
Leukocyte Typing II
None
Modern Trends in Human Leukemia VII
Organized on behalf of the Deutsche Gesellschaft für Hämatologie und Onkologie, Hamburg, June 27/28, 1986
Microenvironments in Haemopoietic and Lymphoid Differentiation
The Novartis Foundation Series is a popular collection of the proceedings from Novartis Foundation Symposia, in which groups of leading scientists from a range of topics across biology, chemistry and medicine assembled to present papers and discuss results. The Novartis Foundation, originally known as the Ciba Foundation, is well known to scientists and clinicians around the world.
Immune Recognition
Immune Recognition is a modified compilation of an experimental leukocyte culture conference about various aspects of macrophage and lymphocyte biology in relation to the eponymous central theme. The book is divided into nine sections. Section I covers non-antigenic signals and receptors for lymphocyte activation; the recognition of chemically modified autologous cells; surface membrane saccharides; and B and T cell activation. Section II is about antigenic signals; the activation of macrophages; and the induction of autosensitization of initiator lymphocytes. Sections III and IV discuss the early membrane and biochemical events in lymphocyte activation. Sections V to IX cover the coupling of cytoplasmic and nuclear events to membrane cycles; cellular and molecular basis of cell recognition and interaction in nonlymphocyte systems; the genetic control of immunocompetent cell interactions; and cellular mechanisms that regulate the immune response. The text is intended for doctors who specialize in immunology and want to know more about the different factors that cause the recognition of the immune system.
Biomedical Platforms
An examination of postwar medicine based on the notion of the biomedical platform--the theoretical and clinical meeting ground between the normal and the pathological.
Body Counts
Contributors include Luc Berlivet (INSERM, CNRS, EHESS, Paris), Alberto Cambrosio (McGill University), Sir Iain Chalmers (James Lind Library, Oxford), Nicholas Dodier (INSERM, CNRS, EHESS, Paris), Michael Donnelly (Bard College), Volker Hess (Humboldt-University), Peter Keating (University of Quebec at Montreal), Ann La Berge (Virginia Tech University), Ilana Löwy (INSERM, CNRS, EHESS, Paris), Harry M. Marks (Johns Hopkins University), Lion Murard (INSERM, CNRS, Paris), Mark Parascandola (National Cancer Institute, Bethesda, Maryland), Theodore M. Porter (University of California at Los Angeles), Andrea Rusnock (University of Rhode Island), Christiane Sinding (INSERM, CNRS, EHESS, Paris), and Ulrich Tröhler (Institut für Geschichte der Medizin der Albert-Ludwigs-Universität).
